Evidence map›Paper›PMID 35052686›Full record

ArticleBiomedicines2021

Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization.

Claudia Ferlito, Vincenzo Visco, Roberto Biselli, Maria Sofia Cattaruzza, Giulia Carreras, Gerardo Salerno, Florigio Lista, Maria Rosaria Capobianchi, Concetta Castilletti, Daniele Lapa and 20 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Surgical outcome of angular deformity correction of lower limbs in rickets: a cross-sectional study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 6 institutions in 1 country.

Claudia FerlitoDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.
Vincenzo ViscoDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.ORCID 0000-0001-5067-3121
Roberto BiselliIspettorato Generale della Sanità Militare, Stato Maggiore della Difesa, Via S. Stefano Rotondo 4, 00184 Roma, Italy.
Maria Sofia CattaruzzaDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185 Roma, Italy.ORCID 0000-0002-7489-3564
Giulia CarrerasIstituto per lo Studio la Prevenzione e la Rete Oncologica, Via Cosimo il Vecchio 2, 50139 Firenze, Italy.
Gerardo SalernoDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.
Florigio ListaDipartimento Scientifico Policlinico Militare di Roma, Esercito Italiano, Via S. Stefano Rotondo 4, 00184 Roma, Italy.
Maria Rosaria CapobianchiLaboratorio di Virologia, IRCCS, Istituto Nazionale Malattie Infettive "Lazzaro Spallanzani", Via Portuense 292, 00149 Roma, Italy.
Concetta CastillettiLaboratorio di Virologia, IRCCS, Istituto Nazionale Malattie Infettive "Lazzaro Spallanzani", Via Portuense 292, 00149 Roma, Italy.ORCID 0000-0001-9819-236X
Daniele LapaLaboratorio di Virologia, IRCCS, Istituto Nazionale Malattie Infettive "Lazzaro Spallanzani", Via Portuense 292, 00149 Roma, Italy.
Guido AntonelliDipartimento di Medicina Molecolare, Sapienza Università di Roma, Viale di Porta Tiburtina 28, 00185 Roma, Italy.
Massimo GentileDipartimento di Medicina Molecolare, Sapienza Università di Roma, Viale di Porta Tiburtina 28, 00185 Roma, Italy.
Maurizio SoriceDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.
Gloria RiitanoDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.
Giuseppe LucaniaDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.
Valeria RiccieriDipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.ORCID 0000-0002-7507-5483
Fabrizio MainieroDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.
Antonio AngeloniDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.
Marco LucarelliDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.ORCID 0000-0002-5538-2494
Giampiero FerragutiDipartimento di Medicina Sperimentale, Sapienza Università di Roma, AOU Policlinico Umberto I, Viale del Policlinico 155, 00161 Roma, Italy.ORCID 0000-0001-6129-4071
Alberto AutoreOsservatorio Epidemiologico della Difesa, Ispettorato Generale della Sanità Militare, Stato Maggiore della Difesa, Via S. Stefano Rotondo 4, 00184 Roma, Italy.
Marco LastillaOsservatorio Epidemiologico della Difesa, Ispettorato Generale della Sanità Militare, Stato Maggiore della Difesa, Via S. Stefano Rotondo 4, 00184 Roma, Italy.
Simonetta SalemiDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.
Michela Ileen BiondoDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.
Andrea Picchianti-DiamantiDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.ORCID 0000-0002-8552-4641
Sara CaporuscioDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.
Raffaela TeloniDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Sabrina MariottiDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Roberto NisiniDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Raffaele D'AmelioDipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy.ORCID 0000-0003-0669-2629
Sapienza University of Rome · ITPoliclinico Umberto I · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITIstituto Superiore di Sanità · ITMinistry of Defence · ITIstituto per lo Studio e la Prevenzione Oncologica · IT

Funding

Italian Ministry of Defense M_DSSMD REG2016 0034813 09032016
6 · The paper itself

Abstract

We previously examined the safety and immunogenicity of multiple vaccines administered to a military cohort, divided into two groups, the first composed of students at military schools, thus operating inside the national borders for at least 3 years, and the other formed of soldiers periodically engaged in a 9-month-long mission abroad (Lebanon). In the current study, we analyzed 112 individuals of this cohort, 50 pertaining to the first group and 62 to the second group, in order to examine the possible late appearance of side effects and to calculate the half-life of the induced antibodies. Moreover, the possible involvement of B-cell polyclonal activation as a pathogenetic mechanism for long term antibody persistence has even been explored. No late side effects, as far as autoimmunity and/or lymphoproliferation appearance, have been noticed. The long duration of the vaccine induced anti-HAV antibodies has been confirmed, whereas the antibodies induced by tetravalent meningococcal polysaccharide vaccine have been found to persist above the threshold for putative protection for a longer time, and anti-tetanus, diphtheria, and polio 1 and 3 for a shorter time than previously estimated. No signs of polyclonal B-cell activation have been found, as a possible mechanism to understand the long antibody persistence.

Indexed as

antibody durabilityantibody persistenceB-cell polyclonal activationsafetyvaccines

Identifiers

PMID35052686
PMCPMC8773007
OpenAlexW4200605725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.